Home
Atlas Venture Associates XI, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/02/09
Trade details
- Type
- Insider sale
- Amount
- $469.12
- Shares · price
- 733 sh · $0.64 a share
- Held after
- 2,019,563 sh
- Trade date
- 24/02/08
- Filed
- 24/02/09
- Days to filing
- 1 days
Sold under 0.1% of holdings
- Share of holding sold
- under 0.1%
Xilio Therapeutics trades, last 26 weeks
What else happened in Xilio Therapeutics around then
Filed or reported within 30 days of the trade day · 24/01/09~24/03/09Atlas Venture Associates XI's recent trades
- Atlas Venture Associates XI
BuySionna Therapeutics
BuySionna Therapeutics
SION
$1.1M
60,000 sh
$1.1M
Filed 25/02/10
Traded 25/02/10
- Atlas Venture Associates XI
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$6.7M
272,923 sh
$6.7M
Filed 24/02/28
Traded 24/02/27
- Atlas Venture Associates XI
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$3.8M
152,244 sh
$3.8M
Filed 24/02/28
Traded 24/02/28
- Atlas Venture Associates XI
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$3.2M
136,312 sh
$3.2M
Filed 24/02/28
Traded 24/02/26
- Atlas Venture Associates XI
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$1.6M
64,783 sh
$1.6M
Filed 24/02/28
Traded 24/02/26